AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Noble Biomaterials Data, Technology Stack, and Enterprise Applications
SCM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
QAD Legacy QAD Production Execution Advanced Planning and Scheduling SCM n/a 2019 2020 In 2019 Noble Biomaterials implemented QAD Production Execution together with QAD Adaptive ERP to support Advanced Planning and Scheduling across its U.S. manufacturing operations. The deployment was scoped to address paper based shop floor reporting and to improve production data accuracy and operational visibility for the companys manufacturing sites in the United States. The implementation of QAD Production Execution focused on shop floor data capture and production tracking capabilities typical of production execution technology, enabling real time shop floor visibility and structured work order reporting. Configuration emphasized capture of production transactions and traceability records to feed downstream billing and quality workflows, with the full application name QAD Production Execution used for shop floor orchestration and recordkeeping. QAD Production Execution was implemented as a companion to QAD Adaptive ERP, integrating execution level transactions with core ERP functions to support invoicing and traceability workflows. Operational coverage was the U.S. region, targeting manufacturing and operations functions to reduce manual tracking efforts and to centralize production data for finance and operations teams. Governance and process changes accompanied the rollout, with operational teams moving from manual paper processes to electronic shop floor reporting and structured production records. As reported by the customer, the project delivered real time shop floor visibility, reduced overtime and manual tracking, and improved traceability and invoicing speed.
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Google Legacy Google Cloud Platform (GCP) Application Hosting and Computing Services IaaS n/a 2021 2021
Application Hosting and Computing Services IaaS 2017 2017
Content Delivery Network IaaS 2016 2016
PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
QAD Legacy QAD Enterprise Platform Apps Development PaaS n/a 2021 2021 In 2021, Noble Biomaterials implemented QAD Enterprise Platform to build a personalized sales forecasting application using QAD’s low and no code application development tools, aligning the project with the Apps Development category. The forecasting solution was developed on the QAD Enterprise Platform and shares the same data lake and user interface as Noble’s QAD Adaptive ERP system, consolidating multiple point solutions onto a single platform. The implementation leveraged QAD Enterprise Platform development capabilities to create configurable forecasting modules and embedded business logic for demand modeling, scenario planning, and automated data ingestion. The new application automated and streamlined the data flow between the forecasting application and the QAD Adaptive ERP system, removing the integration friction that had existed with Noble’s earlier forecasting implementation. Operational scope centered on the sales forecasting team with downstream visibility to supply chain and finance stakeholders through the unified QAD interface and data lake. The deployment simplified access to forecast data and standardized workflow orchestration for forecasting reviews, version control, and periodic reforecast cycles within the QAD environment. By consolidating multiple solutions under the QAD Enterprise Platform, Noble Biomaterials eliminated separate software costs while improving its sales forecasting team’s productivity by 35 percent and delivering more accurate and timely forecasts for the organization. Nucleus Research also found that QAD’s low and no code tools produced a rapid development cycle and high levels of customization, enabling Noble to extend functionality of its QAD Adaptive ERP at relatively low costs.
Transactional Email PaaS 2020 2020
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Collaboration Collaboration 2018 2018
Collaboration Collaboration 2019 2019
ERP Services and Operations
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Manufacturing ERP ERP Services and Operations 2012 2012
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Marketing Automation CRM 2020 2020
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Insight Source
Secure Email Gateways (SEGs), Archive as a Service (AaaS) CyberSecurity 2017 2017
IT Decision Makers and Key Stakeholders at Noble Biomaterials
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Noble Biomaterials Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Noble Biomaterials Technographics

Noble Biomaterials is a Manufacturing organization based in United States, with around 150 employees and annual revenues of $20.0 million.

Noble Biomaterials operates a diverse technology stack with applications such as QAD Production Execution, Google Cloud Platform (GCP) and QAD Enterprise Platform, covering areas like Advanced Planning and Scheduling, Application Hosting and Computing Services and Apps Development.

Noble Biomaterials has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as QAD and Google.

Noble Biomaterials recently adopted applications including Google Cloud Platform (GCP) in 2021, QAD Enterprise Platform in 2021 and Twilio Sendgrid in 2020, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Noble Biomaterials’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Noble Biomaterials’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Noble Biomaterials technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.